Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man. 1987

R E Galinsky, and E B Nelson, and D E Rollins
Department of Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City.

This study examined the effect of metyrapone on the elimination rate of acetaminophen and on the apparent formation rate of acetaminophen metabolites in man. Metyrapone treatment, 1.5 g, increased the half-life of acetaminophen, decreased the fraction of the dose recovered in the urine as the glucuronide and increased the fraction of the dose recovered in urine as the sulfate and mercapturate conjugates. The apparent rate constant for the formation of acetaminophen glucuronide was significantly decreased by metyrapone while the apparent rate constants for the formation of the sulfate and mercapturic acid metabolites were unchanged or slightly increased, respectively. These data indicate that metyrapone inhibits acetaminophen glucuronidation and possibly enhances the oxidation of acetaminophen to its quantitatively minor yet highly toxic reactive metabolite. The extent to which the parallel pathways of acetaminophen elimination are also affected by inhibitors of cytochrome P-450-mediated oxidation will limit the efficacy of these types of potential antidotes for the treatment of acetaminophen overdose.

UI MeSH Term Description Entries
D008297 Male Males
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas

Related Publications

R E Galinsky, and E B Nelson, and D E Rollins
January 1982, Drug metabolism reviews,
R E Galinsky, and E B Nelson, and D E Rollins
April 1979, American journal of hospital pharmacy,
R E Galinsky, and E B Nelson, and D E Rollins
October 1981, The Journal of pharmacology and experimental therapeutics,
R E Galinsky, and E B Nelson, and D E Rollins
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
R E Galinsky, and E B Nelson, and D E Rollins
January 1988, Biochemical pharmacology,
R E Galinsky, and E B Nelson, and D E Rollins
April 1988, Bollettino chimico farmaceutico,
R E Galinsky, and E B Nelson, and D E Rollins
July 1972, European journal of pharmacology,
R E Galinsky, and E B Nelson, and D E Rollins
January 1968, Chemotherapia,
R E Galinsky, and E B Nelson, and D E Rollins
October 1978, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!